Marijuana Legalization Won’t Happen in New York in 2020
New York lawmakers decided to delay marijuana legalization due to the COVID-19 pandemic. As a result, New York won't see marijuana legalization in 2020.
Comparing OrganiGram and Aphria’s Valuation Multiples
So far this year, OrganiGram Holdings (NASDAQ:OGI) and Aphria (NYSE:APHA) have lost 11.0% and 36.7% of their stock price.
Massachusetts: No Adult-Use Cannabis Sales amid COVID-19
Cannabis sales continue to rise due to increased demand amid the coronavirus outbreak. Globally, the coronavirus chaos has caused panic and anxiety.
Analysts Cut Target Prices after HEXO’s Q2 Earnings
Hexo (TSE:HEXO) reported its second-quarter earnings on March 30. For the quarter, the company missed analysts' revenue expectations marginally.
Cronos Group: Wall Street Is Bearish after Its Earnings
Cronos Group (NASDAQ:CRON) disappointed investors with its fourth-quarter results on March 30. The company's revenue was way below analysts' estimates.
MedMen Withdrew Its Guidance amid COVID-19 Pandemic
MedMen stock fell by 12.0% on March 30 after the company released some corporate updates. MedMen has been struggling with a cash crunch.
Is There More Upside to Cresco Labs’ Stock Price?
Amid the weakness in the global financial markets due to the COVID-19 outbreak, Cresco Labs fell to a low of 2.81 Canadian dollars on March 17.
Why Were Cronos Group’s Q4 Earnings a Shipwreck?
Cronos Group reported its fourth-quarter and fiscal 2019 results on Monday after the market closed. The company's fourth-quarter results were disappointing.
Should You Consider Buying Aurora Cannabis?
Aurora Cannabis (NYSE:ACB) is one of the few cannabis companies that has lost more than half of its market capitalization this year.